Executive record

Joseph Oliveto

Director at Milestone Pharmaceuticals Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:joseph-olivetoVersion: public-0As of: 2026-09-30

Not yet claimed9 published Claims3 sources
  • Director

Key Claims

Biography

Mr. Oliveto brings more than 30 years of pharmaceutical and biotech experience across drug development, commercialization, manufacturing and business development. He has served as President and CEO of Milestone since 2017 with a track record of successful late-stage development, FDA approvals and strategic transactions.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Dates not publishedExecutive title: President and Chief Executive Officer · Organization not publishedMIST DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. MIST DEF 14A director slate

    sec filing · Source published: Apr 30, 2025 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Milestone Pharmaceuticals Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: President and Chief Executive Officer · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  2. Open source

    sec proxy · Source published: Apr 30, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at Milestone Pharmaceuticals Inc. · Claim reviewed: May 16, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Milestone Pharmaceuticals Inc. · Claim reviewed: May 16, 2026